13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

From Seed to Series A: What will spark investors’ interest in 2024?

Edition

From Seed to Series A: What will spark investors’ interest in 2024?

As we approach the end of the year, it’s time to take stock of the exciting landscape of pre-seed, seed and Series A funding in Europe and beyond. With a constant stream of innovations driving the biotech industry, what are the investment opportunities to watch for in 2024? Which models, therapeutic areas or innovative technologies are currently capturing the spotlight? What are investors’ expectations regarding project maturity? How can early-stage biotech companies position themselves to be highly attractive for investment? Could we see a rise in pre-seed and seed money for 2024?

Moderator: Alexander Sinclair-Wilson, Associate Director of Investments, Sanofi Ventures

Adrien Clavairoly

Senior Associate
France
AdBio Partners

Juliette Lee

Associate
The Netherlands
EQT Life Sciences Dementia Fund

Anela Vukoja

COO
Germany
Apollo Health Ventures

Tim Haines

Executive Partner
United Kingdom
Abingworth
Scroll to Top
  • No products in the cart.